Abbott Rachel J, Pachnio Annette, Pedroza-Pacheco Isabela, Leese Alison M, Begum Jusnara, Long Heather M, Croom-Carter Debbie, Stacey Andrea, Moss Paul A H, Hislop Andrew D, Borrow Persephone, Rickinson Alan B, Bell Andrew I
Institute of Immunology and Immunotherapy, University of Birmingham, Birmingham, United Kingdom.
Nuffield Department of Clinical Medicine, University of Oxford, Oxford, United Kingdom.
J Virol. 2017 Oct 13;91(21). doi: 10.1128/JVI.00382-17. Print 2017 Nov 1.
Epstein-Barr virus (EBV) is typically acquired asymptomatically in childhood. In contrast, infection later in life often leads to infectious mononucleosis (IM), a febrile illness characterized by anti-EBV IgM antibody positivity, high loads of circulating latently infected B cells, and a marked lymphocytosis caused by hyperexpansion of EBV-specific CD8 T cells plus a milder expansion of CD56 NKG2A KIR natural killer (NK) cells. How the two situations compare is unclear due to the paucity of studies on clinically silent infection. Here we describe five prospectively studied patients with asymptomatic infections identified in a seroepidemiologic survey of university entrants. In each case, the key blood sample had high cell-associated viral loads without a marked CD8 lymphocytosis or NK cell disturbance like those seen in patients during the acute phase of IM. Two of the cases with the highest viral loads showed a coincident expansion of activated EBV-specific CD8 T cells, but overall CD8 T cell numbers were either unaffected or only mildly increased. Two cases with slightly lower loads, in whom serology suggests the infection may have been caught earlier in the course of infection, also showed no T or NK cell expansion at the time. Interestingly, in another case with a higher viral load, in which T and NK cell responses were undetectable in the primary blood sample in which infection was detected, EBV-specific T cell responses did not appear until several months later, by which time the viral loads in the blood had already fallen. Thus, some patients with asymptomatic primary infections have very high circulating viral loads similar to those in patients during the acute phase of IM and a cell-mediated immune response that is qualitatively similar to that in IM patients but of a lower magnitude. However, other patients may have quite different immune responses that ultimately could reveal novel mechanisms of host control. Epstein-Barr virus (EBV) is transmitted orally, replicates in the throat, and then invades the B lymphocyte pool through a growth-transforming latent infection. While primary infection in childhood is usually asymptomatic, delayed infection is associated with infectious mononucleosis (IM), a febrile illness in which patients have high circulating viral loads and an exaggerated virus-induced immune response involving both CD8 T cells and natural killer (NK) cells. Here we show that in five cases of asymptomatic infection, viral loads in the blood were as high as those in patients during the acute phase of IM, whereas the cell-mediated responses, even when they resembled those in patients during the acute phase of IM in timing and quality, were never as exaggerated. We infer that IM symptoms arise as a consequence not of the virus infection but of the hyperactivated immune response. Interestingly, there were idiosyncratic differences among asymptomatic cases in the relationship between the viral load and the response kinetics, emphasizing how much there is still to learn about primary EBV infection.
爱泼斯坦-巴尔病毒(EBV)通常在儿童期无症状感染。相比之下,成年后感染往往会导致传染性单核细胞增多症(IM),这是一种发热性疾病,其特征为抗EBV IgM抗体呈阳性、循环中潜伏感染B细胞数量众多,以及由EBV特异性CD8 T细胞过度扩增和CD56 NKG2A KIR自然杀伤(NK)细胞轻度扩增引起的显著淋巴细胞增多。由于对临床无症状感染的研究较少,尚不清楚这两种情况有何不同。在此,我们描述了在一项针对大学新生的血清流行病学调查中前瞻性研究的5例无症状感染患者。在每例患者中,关键血样的细胞相关病毒载量都很高,但没有出现像IM急性期患者那样明显的CD8淋巴细胞增多或NK细胞紊乱。病毒载量最高的2例患者同时出现了活化的EBV特异性CD8 T细胞扩增,但总体CD8 T细胞数量未受影响或仅略有增加。另外2例病毒载量略低的患者,血清学提示感染可能在病程早期就已发生,当时也未出现T细胞或NK细胞扩增。有趣的是,在另一例病毒载量较高的患者中,在检测到感染的初次血样中未检测到T细胞和NK细胞反应,直到数月后才出现EBV特异性T细胞反应,此时血液中的病毒载量已经下降。因此,一些无症状初次感染患者的循环病毒载量与IM急性期患者非常高,且细胞介导的免疫反应在性质上与IM患者相似,但程度较低然而,其他患者可能有截然不同的免疫反应,最终可能揭示宿主控制的新机制。爱泼斯坦-巴尔病毒(EBV)通过口腔传播,在咽部复制,然后通过生长转化潜伏感染侵入B淋巴细胞库。虽然儿童期的初次感染通常无症状,但延迟感染与传染性单核细胞增多症(IM)有关,这是一种发热性疾病,患者循环病毒载量高,且病毒诱导的免疫反应过度,涉及CD8 T细胞和自然杀伤(NK)细胞。在此我们表明,在5例无症状感染病例中,血液中的病毒载量与IM急性期患者一样高,而细胞介导的反应,即使在时间和性质上与IM急性期患者相似,也从未如此过度。我们推断,IM症状的出现不是病毒感染的结果,而是免疫反应过度激活的结果。有趣的是,无症状病例在病毒载量与反应动力学之间的关系存在独特差异,这凸显了我们对EBV初次感染仍有很多需要了解的地方。